SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-24-001812
Filing Date
2024-07-29
Accepted
2024-07-29 08:11:56
Documents
14
Period of Report
2024-07-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210175-8k_biomx.htm   iXBRL 8-K 42855
  Complete submission text file 0001013762-24-001812.txt   261848

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20240723.xsd EX-101.SCH 3805
3 XBRL DEFINITION FILE phge-20240723_def.xml EX-101.DEF 26681
4 XBRL LABEL FILE phge-20240723_lab.xml EX-101.LAB 36840
5 XBRL PRESENTATION FILE phge-20240723_pre.xml EX-101.PRE 25305
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0210175-8k_biomx_htm.xml XML 5820
Mailing Address 708 QUINCE ORCHARD RD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD RD SUITE 205 GAITHERSBURG MD 20878 844-972-0500
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 823364020 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 241149026
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)